The first session of play belonged to Sri Lanka skipper Charith Asalanka who cracked a century for his side to make a modest 244 and in the second sesion spin duo ...

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.

More than 90% of patients living with PDAC have tumors carrying a RAS cancer driver mutation with ~85% carrying a KRAS G12 mutation. Revolution Medicines is currently enrolling patients in ...